STOCK TITAN

GRI Bio (GRI) S-1 Filings

GRI NASDAQ

Here are the S-1 registration statements from GRI Bio, Inc. (GRI) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

An S-1 covers the registration statement a company files to sell shares publicly, so if you follow GRI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GRI filings page.

Rhea-AI Summary

GRI Bio, Inc., a Delaware-based biotechnology company headquartered in La Jolla, California, filed Amendment No. 1 to its Form S-1 registration statement. This amendment is described as an exhibits-only filing, meaning it primarily updates and compiles legal and contractual documents without changing the main disclosure sections. The exhibit list includes various forms of common stock purchase warrants, pre-funded warrants, Series F warrants, a form of securities purchase agreement, an updated engagement letter with H.C. Wainwright & Co., an equity incentive plan and related award agreements, key employment and consulting agreements, consents, and the filing fee table. The amendment is signed on behalf of the company by President and Chief Executive Officer W. Marc Hertz, Ph.D., and other directors and officers.